嘉华股份(603182) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 was CNY 347,563,629.15, a decrease of 11.79% compared to CNY 394,014,949.66 in the same period last year[4] - Net profit attributable to shareholders increased by 14.35% to CNY 35,714,134.90 from CNY 31,232,701.74 year-on-year[4] - Total revenue for Q1 2025 was CNY 347,563,629.15, a decrease of 11.8% compared to CNY 394,014,949.66 in Q1 2024[16] - Net profit for Q1 2025 increased to CNY 35,714,134.90, compared to CNY 31,232,701.74 in Q1 2024, representing a growth of 14.0%[17] - Basic and diluted earnings per share rose by 15.79% to CNY 0.22 from CNY 0.19 in the same period last year[4] - Basic and diluted earnings per share for Q1 2025 were both CNY 0.22, up from CNY 0.19 in Q1 2024[18] Cash Flow - The net cash flow from operating activities was CNY 48,277,455.90, showing a slight increase of 1.39% compared to CNY 47,617,500.35 in the previous year[4] - The company’s cash flow from operating activities showed improvement, contributing positively to the overall financial health[16] - In Q1 2025, the cash inflow from operating activities was CNY 417,455,432.64, slightly down from CNY 419,457,949.95 in Q1 2024, representing a decrease of approximately 0.48%[20] - The net cash flow from operating activities for Q1 2025 was CNY 48,277,455.90, an increase from CNY 47,617,500.35 in Q1 2024, reflecting a growth of about 1.39%[21] - The cash outflow for investing activities in Q1 2025 was CNY 9,206,300.20, significantly lower than CNY 31,446,829.19 in Q1 2024, indicating a reduction of approximately 70.7%[21] - The net cash flow from investing activities for Q1 2025 was -CNY 9,058,128.69, an improvement compared to -CNY 31,446,829.19 in Q1 2024[21] - The cash outflow from financing activities in Q1 2025 was CNY 5,148,166.66, down from CNY 35,139,875.00 in Q1 2024, showing a decrease of about 85.3%[22] - The net increase in cash and cash equivalents for Q1 2025 was CNY 35,735,268.16, contrasting with a decrease of CNY 18,312,209.10 in Q1 2024[22] - The ending balance of cash and cash equivalents as of the end of Q1 2025 was CNY 183,012,749.51, compared to CNY 287,810,482.13 at the end of Q1 2024[22] Assets and Equity - Total assets at the end of Q1 2025 were CNY 1,465,468,000.56, reflecting a 2.33% increase from CNY 1,432,076,811.08 at the end of the previous year[5] - Total equity attributable to shareholders increased to CNY 1,111,255,998.82 from CNY 1,075,317,844.81[14] - Shareholders' equity attributable to the parent company increased by 3.34% to CNY 1,111,255,998.82 from CNY 1,075,317,844.81 at the end of the previous year[5] - Total liabilities amounted to CNY 354,212,001.74, slightly down from CNY 356,758,966.27[14] Research and Development - Research and development expenses for Q1 2025 were CNY 2,505,340.70, compared to CNY 1,617,262.23 in Q1 2024, indicating a significant increase of 54.8%[17] Shareholder Information - The total number of common shareholders at the end of the reporting period was 9,555[8] - The top shareholder, Zhang Guanling, holds 22,372,688 shares, representing 13.60% of the total shares[8] Other Information - Non-recurring gains and losses included government subsidies of CNY 700,000 and other non-operating income of CNY 2,000.00[6] - The company has not disclosed any significant new product developments or market expansion strategies in this report[10]